Insights & Updates

Financial Wisdom for the Plant Medicine Frontier

Expert tax strategies, regulatory news, and financial best practices tailored for cannabis and psychedelic business leaders.

Advocating for Flexibility: Oregon’s Psilocybin Industry Must Adapt to Stay Ahead

To the Oregon psilocybin industry, the upcoming public comment period offers a critical opportunity to advocate for more flexible regulations that align...
Read post

The Future of Hemp in Oregon: A Call to Action with Courtney Moran

In this important conversation, Justin Botillier, CEO of Calyx CPA, sits down with Courtney Moran of Earth Law LLC to discuss the recent OLCC public...
Read post

The Cannabis Journey Back to the Supreme Court: A Conversation with Katie Scates, CPA, JD

Join Justin Botillier, CEO of Calyx CPA, in a candid conversation with Katie Scates, CPA, JD, the newest member of the Calyx CPA team. With her extensive...
Read post

Navigating Oregon’s Cannabis Certificate of Compliance: Insights from Attorney Kevin Jacob

Navigating Oregon’s Certificate of Compliance Requirements for Cannabis Retailers In this informative video, Kevin Jacoby, owner of Jacoby Law, shares valuable insights into Oregon’shttps://youtu.be/uGd3jwHzwLE Navigating Oregon’s Certificate of Compliance Requirements for Cannabis Retailers In this informative video, Kevin Jacoby, owner of Jacoby Law, shares valuable insights into Oregon’s
Read post

When Will Marijuana Be Rescheduled? ChatGpt’s Prediction!

As we stand on the cusp of a historic shift in U.S. drug policy, the potential rescheduling of cannabis from Schedule I to Schedule III is a topic of...
Read post

Bad News: Major Setback for the Psychedelics Industry: FDA Denies MDMA Therapy

The psychedelics industry has recently faced a significant setback as the U.S. Food and Drug Administration (FDA) denied Lykos Therapeutics’ approval request for MDMA-assisted therapy for PTSD. This decision has cast a shadow on the burgeoning field of psychedelic-assisted therapies, which has been gaining momentum over the past few years.
Read post

The Future of the Ordinary Business Deduction for Cannabis Businesses

We recently ran across an article written in May by Joseph A. Peterson, a Senior Attorney at Plunkett Cooney, called Beyond 280E: The Future of the Ordinary Business Deduction for Cannabis Businesses. His article again highlights how 280E has damaged the cannabis business and argues that companies have the constitutional right to claw back their lost deductions. See Justin’s video, which he recorded back in March.
Read post

A Case of Strategic Silence: IRS Guidance on Section 471(C) & Section 280E

In true IRS fashion, the memorandum recently brought to our attention explicitly avoids addressing the application of Section 471(c) in mitigating the...
Read post

Psycon Las Vegas: Navigating Tax Challenges in the Psychedelic Industry

Taxation Challenges in the Psychedelic Industries At the recent PsyCon Convention in Las Vegas, Justin Botillier of Calyx CPA based in Medford, Oregon, delivered
Read post

“Is the Dea’s Response to Rescheduling Cannabis Overly Hyped?” Calyx Responds……

Cannabis Rescheduling and the IRS’s Response to Business Deductions The recent decision by the Drug Enforcement Administration (DEA) to consider rescheduling marijuana under the
Read post

CALIFORNIA’S PIONEERING LEGISLATION FOR PSYCHEDELIC THERAPY

In an era where mental health innovation is more crucial than ever, California stands at the forefront of a transformative shift. The recent passage of...
Read post

INSIGHTS ON AMENDING RETURNS & NAVIGATING LEGAL CHANGES

Insights on Amending Returns and Navigating Legal Changes Join Justin Botillier and Jamie Jorgenstone as they delve into the complexities of amending tax returns
Read post
Untitled UI logotext
Join our newsletter to stay up to date on features and releases.
Subscribe
We care about your data in our privacy policy.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2021 calyxcpa.com. All rights reserved.